No Detail Found!

Correlation Between Rectus Femoris Muscle Cross-Sectional Area and Severity of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Author(s)
Wei Wang Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Hongju Bao Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Feng Zhu Department of Ultrasound, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Lingyun Dong Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Xiaoyun Hu Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Weizhen Song Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University,Jiangsu,China
Abstract
Objective: To assess the correlation between rectus femoris muscle cross-sectional area (RFCSA) and the severity of acute exacerbations of chronic obstructive pulmonary disease (ECOPD). Study Design: Observational study. Place and Duration of the Study:Respiratory and Critical Care Medicine Ward, Suzhou Ninth Hospital a liated to Soochow University, Suzhou, Jiangsu, China, from May 2021 to April 2024. Methodology: Data of seventy-two ECOPD patients were collected regarding their gender, age, height, and weight. The patients'RFCSA, the Forced Expiratory Volume in 1 second predicted (FEV1% predicted), the COPD assessment test (CAT), and the modi ed Medical Research Council (mMRC) Dyspnoea Scale were determined. To analyse the data, the patients were divided into four groups, the groups were classi ed as: Mild group (the value of FEV1% predicted 80% or more), moderate group (the value of FEV1% predicted between 50% and 79%), severe group (the value of FEV1% predicted between 30% and 49%), and very severe group (the value of FEV1% predicted 30% or less). Results: There were signi cant di erences inRFCSA (H 41.80, p <0.001), FEV1% predicted (H 63.91, p <0.001), and CAT (H 24.50, p <0.001) among the four groups.RFCSA, FEV1% predicted, and CAT varied signi cantly among the groups. In ECOPD patienRtFsC, SA showed positive relationship with FEV1% predicted (r = 0.75, p <0.001). A strong negative correlation was obtained betweenRFCSA and CAT in ECOPD patients (r = -0.69, p <0.001). Conclusion: RFCSA may be an indicator for evaluating the severity of ECOPD.
Publication Details
Page(s) 331-334
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Forced expiratory volume in 1 second predicted, Exacerbations of chronic obstructive pulmonary disease, Rectal muscle cross-sectional area, Modi ed medical research council, COPD assessment test
References
Agusti A,Celli BR,Criner GJ,Halpin D,Anzueto A,Barnes P .2023 .Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J, 10(4) : 00239-2023.
Meiwald A,Adams RG,Rowlandson A,Ma Y,Watz H,Ichinose M .2022 .Germany: Common barriers to optimal COPD care. Int J Chron Obstruct Pulmon Dis, 0983(1) : 1507-21.
Trivedi A,Bade G,Madan K,Bhat MA,Guleria R,Talwar A .2022 .E ect of Smoking and Its Cessation on the transcript pro le of peripheral monocytes in COPD patients. Int J Chron Obstruct Pulmon Dis, 10 : 65-77.
Wang C,Xu J,Yang L,Xu Y,Zhang X,Bai C .2018 .Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): A national cross-sectional study. Lancet, 6736(18) : 30841-9.
Chen S,Kuhn M,Prettner K,Yu F,Yang T,Barnighausen T .2023 .The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: A health-augmented macroeconomic modelling study. Lancet Glob Health, 10(23) : 00217-6.
MacDonell R,Woods O,Whelan S,Cushen B,Carroll A,Brennan J .2020 .Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: A scoping review. BMJ Open Respir Res, 10(1) : .
Forder A,Zhuang R,Souza VGP,Brockley LJ,Pewarchuk ME,Telkar N .2023 .Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. Int J Mol Sci, 10(3) : 2859.
Everaerts S,McDonough JE,Verleden SE,Josipovic I,Boone M,Dubbeldam A .2019 .Airway morphometry in COPD with bronchiectasis: A view on all airway generations. Eur Respir J, 10(5) : 02166-2018.
Latimer LE,Constantin D,Greening NJ,Calvert L,Menon MK,Steiner MC .2019 .Impact of transcutaneous neuromuscular electrical stimulation or resistance exercise on skeletal muscle mRNA expression. Int J Chron Obstruct Pulmon Dis, 10 : 1355-64.
Han L,Li P,He Q,Yang C,Jiang M,Wang Y .2023 .Revisiting skeletal muscle dysfunction and exercise in chronic obstructive pulmonary disease: Emerging signi cance of myokines. Aging Dis, 1125(6) : 2453-69.
Waejien-Smit K,Crutsen M,Keene S,Miravitlles M,Crisafulli E,Torres A .2024 .Global mortality and readmission rates following COPD exacerbation-related hospitalisation: A meta-analysis of 65 945 individual patients. ERJ Open Res, 10(1) : 00838-2023.
Alqahtani JS,Oyelade T,Sreedharan J,Aldhahir AM,Alghamdi SM,Alrajeh AM .2020 .Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review. BMJ Open Respir Res, 10(1) : .
Puthucheary ZA,McNelly AS,Rawal J,Connolly B,Sidhu PS,Rowlerson A .2017 .Rectus femoris cross-sectional area and muscle layer thickness: Comparative markers of muscle wasting and weakness. Am J Respir Crit Care Med, 10(1) : 0875LE-8.
Abdulai RM,Jensen TJ,Patel NR,Polkey MI,Jansson P,Celli BR .2018 .Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 10(4) : 0615CI-49.
Kume H,Yamada R,Sato Y,Togawa R .2023 .Airway smooth muscle regulated by oxidative stress in COPD. , 10(1) : 142.
Shen Y,Wang L,Wu Y,Ou Y,Lu H,Yao X. .2021 .A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease. Exp Ther Med, 10149(1) : 717.
Nan Y,Zhou Y,Dai Z,Yan T,Zhong P,Zhang F .2023 .Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia. Front Nutr, 1214684 : 1214684.
Cheng SL,Lin CH,Wang CC,Chan MC,Hsu JY,Hang LW .2018 .Comparison between COPD assessment test (CAT) and modi ed medical research council (mMRC) dyspnoea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients. J Formos Med Assoc, 06(1Pt3) : 429-35.
0

Citations

0

Downloads

87

Views